ACA

Brace for a barrage of biosimilarsThe next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.
How Americans really feel about the AHCAA new Kaiser poll has surprising results and three important findings.
Missing this data can hurt your population health strategiesKey socioeconomic data that will help you care for your most vulnerable populations.
ACA exchanges: Who's in, who's out?What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.
AHCA next steps: 4 things MCOs should knowWhat are the next steps for the bill, and how likely is it that it will become law? Here’s are four things MCOs should know.
Opinion: Biggest problems with single-payer ‘Medicare-for-all’Our policy analyst explains why he believes single payer Medicare-for-all is a pipe dream.
Top ACA provisions employers want to keepA Willis Towers Watson survey finds that employers see enhancing the employee experience in healthcare as key to boosting health engagement.
Five Facts About U.S. Drug Spending
Five Facts About U.S. Drug SpendingWhat you need to know about prescription drugs in America.
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Keep up with patient demands: Tips for MCOsPatients are demanding more from payers and providers. Here’s how technology can help.